Jun 16,2022

Point32Health & OncoHealth Collaborate to Provide Digital Telehealth Services to Members with Cancer

Point32Health, the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, and OncoHealth, the leading digital health company dedicated to oncology, today kicked off a collaboration aimed at improving clinical outcomes, enhancing the quality of life, and providing personalized supportive care for members who are facing cancer. In the first stage of the phased pilot, Point32Health’s implementation of Iris™ by OncoHealth, a digital telehealth service for people with cancer, will be offered to eligible Harvard Pilgrim Health Care members in Massachusetts, New Hampshire, and Maine.

COLLABORATION PARTNERSHIP

#insurance

#telehealth

View Analyst & Ambassador Comments
Go to original news
Jul 29,2022

AI System that Mimics Human Gaze could be Used to Detect Cancer

A cutting-edge artificial intelligence (AI) system that can accurately predict the areas of an image where a person is most likely to look has been created by scientists at Cardiff University. Based on the mechanics of the human brain and its ability to distinguish between different parts of an image, the researchers say the novel system more accurately represents human vision than anything that has gone before.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jun 13,2022

Siemens Healthineers Introduces Symbia Pro.specta SPECT/CT Scanner

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging technologies. Capabilities include a low-dose CT of up to 64 slices for impressive detail, automatic SPECT motion correction for additional image clarity, and an intuitive and automated workflow to guide the user through the entire decision-making process of the examination. Designed to replace the Symbia Intevo™ family of SPECT/CT scanners, Symbia Pro.specta is an all-purpose system that can be customized to accommodate a wide range of clinical exams, patient types, and department settings.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jun 07,2022

Jasper Health collaborates with Walgreens to bring customers empathetic, human-led cancer support

Jasper Health today announced that the company’s digital services for cancer care support are now available through the Walgreens Find Care® platform. Jasper Health recently introduced its Coach+ service to its offerings, providing members with additional support for their mental health, sleep, nutrition, physical activity, and financial needs. By leveraging chat, telemedicine, and human coaching, Jasper Coach+ meets member needs whenever and however they want, lessening the complexities of cancer care. With the addition of Jasper and Jasper Coach+ to Walgreens Find Care®, users can access services for cancer care support—from diagnosis through remission and beyond.

COLLABORATION PARTNERSHIP

#institution

#coaching

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 09,2022

AdhereTech and Massive Bio Announce AI-Enabled, Patient-Centric Oncology Solutions Partnership

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology, and AdhereTech, a leading provider of smart devices that connect patients to care with real-time interventions, announced their partnership to provide advanced, data-driven digital health technology solutions, focusing in oral oncolytic agents providing real-time integrated access to care for cancer patients to precision oncology drugs and leading-edge clinical trials. Massive Bio and AdhereTech have committed to combining their products and services to offer global, comprehensive solutions to measure, analyze and monitor precision oncology medication adherence for patients participating in clinical trials and those prescribed commercially available treatments.

COLLABORATION PARTNERSHIP

#product & service

#rwd

#rwe

View Analyst & Ambassador Comments
Go to original news
Jun 16,2022

Welby 70% of breast cancer patients answered that they would like to use PHR/PRO to share information with medical staff and report adverse events

On June 15, Welby conducted a clinical study using PHR/PRO for breast cancer patients at Showa University, and 70% of the patients continued to use the PHR app for communicating with medical staff and reporting adverse events. I announced the results of the research that I want to do. Seigo Nakamura, director of the Breast Center at Showa University Hospital, said, "Accurately understanding patient complaints is said to lead to improved treatment results. Skillful use of the PHR app will improve the relationship between medical staff and patients. But I hope that it will become closer," he commented.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 27,2022

SomaLogic Partners with OncoHost for Precision Cancer Diagnostics

Proteomics technology company SomaLogic signed a licensing agreement with OncoHost, a global provider in next-generation precision oncology for personalized cancer therapy, to develop new cancer diagnostics solutions. As part of the agreement, OncoHost will license SomaLogic’s SomaScan Platform to develop proteomics tests for its PROphet diagnostic system, designed to predict patient response to immunotherapy treatments and provide strategies to overcome treatment resistance. The collaboration reflects SomaLogic’s commitment to leveraging its assay capabilities in the development of high-plex proteomic diagnostic tests.

COLLABORATION PARTNERSHIP

#r&d

#platform

View Analyst & Ambassador Comments
Go to original news
Jul 14,2022

optimune is now reimbursable: For women after initial breast cancer treatment to return to a healthy life

After completing the initial treatment for breast cancer, the patients find themselves on an emotional rollercoaster ride. The online program optimune supports users in establishing healthy habits that can help them strengthen their immune system to stay healthy in the long term. To do this, it uses methods of cognitive behavioral therapy. optimune increases the quality of life and thus strengthens the immune system. Now, optimune can be prescribed by doctors – especially gynecologists – and psychotherapists on prescription. Because the online program was approved by the Federal Institute for Drugs and Medical Devices (BfArM) as a medical device that can be prescribed and is therefore reimbursed by statutory health insurance.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jul 05,2022

Interoperability – The core tool to execute Karkinos Healthcare’s democratized cancer care

Karkinos Healthcare is on a mission to make the best oncology care accessible to anyone who needs it from anywhere. The company is dedicated to delivering the 4Ds: Detection, Diagnosis, Delivery, and Data in cancer care. Apart from the intention to offer democratized and distributed cancer care services in a participatory manner, Karkinos Healthcare is working to develop a Phygital Metaverse for Oncology, in which patients receive the best possible care and direction from care experts stationed anywhere on the planet, either through digital mediums or in physical care centers, closer to their homes.

PRODUCT

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jul 13,2022

Addressing accessibility and affordability in cancer care with a distributed approach

In a country like India, where the burden of the disease is high and because of the skew in care provision, while tremendous efforts are being put in identifying the different types of cancers and their precise treatment for each patient, a Distributed Cancer Care approach is an absolute necessity to take cancer care closer to the people (including creating awareness about cancer and helping detect it early). At Karkinos, the company is working towards setting up the country-wide Distributed Cancer Care Network to provide citizens with quality cancer care closer to home, which is also affordable and accessible.

PRODUCT

#platform

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY